A nurse is assessing a client who is taking combination oral contraceptives. Which of the following findings should the nurse report to the provider immediately?
Leg tenderness
Cramps
Nausea
Abdominal bloating
The Correct Answer is A
A. Leg tenderness: Leg tenderness can be a sign of deep vein thrombosis (DVT), a rare but serious complication associated with oral contraceptives. Therefore, the nurse should report this finding immediately for further evaluation and management to prevent complications such as pulmonary embolism.
B. Cramps: Mild cramps are a common side effect of oral contraceptives and do not typically require immediate reporting unless they are severe or persistent.
C. Nausea: Nausea is a common side effect of oral contraceptives, especially during the initial weeks of use. It usually improves over time and does not typically require immediate reporting unless it is severe or persistent.
D. Abdominal bloating: Abdominal bloating is a common side effect of oral contraceptives and is usually mild and self-limiting. It does not typically require immediate reporting unless it is severe or persistent.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. The client has a history of anaphylaxis following a bee sting: This finding is not directly related to the safety of taking alendronate for osteoporosis.
B. The client has a first-degree relative who has Paget's disease: While family history is
important in assessing the risk of osteoporosis, it is not a direct safety risk for taking alendronate.
C. The client is postmenopausal: Postmenopausal status is a common indication for the use of alendronate to prevent or treat osteoporosis. It is not a safety risk.
D. The client has immobility that restricts her to a supine position: Immobility, especially in a supine position, can increase the risk of esophageal irritation and reflux when taking alendronate. Therefore, this finding poses a safety risk for the client when taking this medication.
Correct Answer is C
Explanation
A. Epoetin alfa is not administered intranasally.
B. Epoetin alfa is not administered orally because it would be destroyed by digestive enzymes and have poor absorption.
C. Epoetin alfa is typically administered subcutaneously, as it is a recombinant human erythropoietin that stimulates red blood cell production.
D. Epoetin alfa is not administered trans dermally.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.